Zdrowie i gospodarka · 30/07/2024
FDA Renews Pharmacy Compounding Advisory Committee Charter for 2 Years
The FDA has announced the renewal of the Pharmacy Compounding Advisory Committee for an additional 2 years, with the new charter set to expire on April 25, 2026, following a determination by the Commissioner of Food and Drugs that it is in the public interest.